the global Immunoassay market is expected to grow at significant CAGR around 4.9% throughout the forecast period and reach around US$ 26.1 billion by 2026.
The report provides analysis of global Immunoassay market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year.
Thanks to rising alcohol and drug testing, the global immunoassay market is growing at a fast pace over the next few years. Some of the key factors estimated for ensuring the development of the immunoassay market over the coming years are the technological developments in this field, together with the advent of new automated systems.
The major factors that are expected to contribute to a market development in the coming years are a significant increase for infectious and chronic diseases and the increase in the use of immunoassays in oncology. It is estimated that the increased geriatric population and technological progress in this area will speed up the overall market growth in the next several years. In the future, a further factor that will lead to potential opportunities for growth are the high development of biopharmaceutical and biotechnological industries.
On the flip side the unfavorable reimbursement environment is estimated to limit the development of the global immunoassay market in the coming years, and strict provisions and regulations relating to approvals of immunoassay consumables and tools. Furthermore, growing complexities are expected to reduce overall market developments in the next few years when performing diagnostic tests. The growing opportunities in the developing countries are nevertheless predicted to secure market growth in the next few years.
North America is anticipated to govern the Immunoassay Market
In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come. In the coming years, the high number of research projects and the existing well-established healthcare infrastructures are projected to speed up the development of the North American immunoassay market. The growth of this region will be expected to be accelerated in the coming years as geriatric populations and the development of the biotechnology and pharmaceutical industries increase. In addition, the growth of Asia-Pacific in the future will be promising, thanks to the increasing number of In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come.
Immunoassay Market by Technology
Immunoassay Market by Product
Immunoassay Market by Application
Immunoassay Market by End-Use
Global Immunoassay Market, by Geography
The market research study on “Immunoassay Market (By Technology: Enzyme Immunoassay (EIA) [Fluorescence Immunoassays (FIA), Chemiluminescence Immunoassays (CLIA)], Radioimmunoassay (RIA), Rapid test, Others; By Product: Analyzers/instruments [Closed ended systems, Open ended systems], Reagents & kits, Software & services; By Application: Endocrinology, Therapeutic drug monitoring, Autoimmune diseases, Infectious disease testing, Cardiology, Others; By End-Use: Hospitals, Pharmaceutical and biotech companies, Clinical laboratories, Academic research centers, Blood banks, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global Immunoassay market segments with market dynamics and their impact.
The key players of the market are Dickinson & Company; Becton, Thermo Fisher Scientific, Inc.; BioMérieux; Siemens Healthineers; Abbott laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho Clinical Diagnostics; and Quidel Corporation.
The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. Market Insights Nonwovens are a unique category of textile product enginee
According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o
According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments. Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The
According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. Market Insights An gr
Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes
Introduction According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i